OptimizeRx Corporation operates a digital healthcare technology platform that connects pharmaceutical manufacturers, healthcare providers, and consumers through targeted messaging and financial solutions. The company's core offering is its Dynamic Audience Activation Platform, which uses machine learning and predictive analytics to identify and reach specific patient populations. The platform enables delivery of brand messaging, therapeutic support information, affordability programs, and patient support resources to healthcare professionals and consumers across multiple digital channels.
The company provides several distinct solutions within its platform architecture. Its Micro-Neighborhood Targeting capability creates consumer audiences using privacy-first methodologies, while its Profiler tool delivers demographic and behavioral insights on target populations. OptimizeRx delivers messages through a broad omnichannel network encompassing programmatic display advertising, connected television, social media, addressable television, digital out-of-home, audio, and direct mail. Additionally, the company offers pharmacy alert systems that flag medication inventory to healthcare facilities, and financial messaging solutions that integrate copay discount information directly into electronic health record and ePrescribing systems used by prescribers.
Based in Waltham, Massachusetts, OptimizeRx operates with approximately 128 full-time employees. The company was incorporated in Nevada and is publicly listed on Nasdaq. Its customer base includes pharmaceutical manufacturers seeking to optimize patient access and awareness programs, as well as healthcare providers and pharmacies utilizing the company's operational and financial messaging tools.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.10 | $-1.10 | -6.8% | |
| 2023 | $-1.03 | $-1.03 | -60.9% | |
| 2022 | $-0.64 | $-0.64 | -3300.0% | |
| 2021 | $0.02 | $0.02 | +113.3% | |
| 2020 | $-0.15 | $-0.15 | +34.8% | |
| 2019 | $-0.23 | $-0.23 | -1250.0% | |
| 2018 | $0.02 | $0.02 | — | |
| 2017 | — | — | — | |
| 2016 | — | $-0.05 | -150.0% | |
| 2015 | — | $-0.02 | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-20 | 0001213900-25-025576 | SEC ↗ |
| 2023-12-31 | 2024-04-15 | 0001213900-24-033000 | SEC ↗ |
| 2022-12-31 | 2023-03-10 | 0001213900-23-019233 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0001213900-22-009736 | SEC ↗ |
| 2020-12-31 | 2021-03-08 | 0001213900-21-013996 | SEC ↗ |
| 2019-12-31 | 2020-03-26 | 0001213900-20-007491 | SEC ↗ |
| 2018-12-31 | 2019-03-12 | 0001213900-19-003962 | SEC ↗ |
| 2017-12-31 | 2018-03-08 | 0001213900-18-002722 | SEC ↗ |
| 2016-12-31 | 2017-03-08 | 0001213900-17-002093 | SEC ↗ |
| 2015-12-31 | 2016-03-15 | 0001213900-16-011609 | SEC ↗ |
| 2014-12-31 | 2015-03-31 | 0001213900-15-002228 | SEC ↗ |
| 2013-12-31 | 2014-03-31 | 0001255294-14-000254 | SEC ↗ |
| 2012-12-31 | 2013-03-12 | 0001255294-13-000182 | SEC ↗ |
| 2011-12-31 | 2012-03-30 | 0001255294-12-000205 | SEC ↗ |
| 2010-12-31 | 2011-03-31 | 0001507718-11-000079 | SEC ↗ |
| 2009-12-31 | 2010-03-31 | 0001255294-10-000244 | SEC ↗ |
| 2008-12-31 | 2009-04-15 | 0001255294-09-000222 | SEC ↗ |